Donate blood and mucus samples to study virus treatments
Part of Infections, Lungs & breathing clinical trials.
This study collects samples from people who currently have, recently had, or may have been exposed to common respiratory viruses. The goal is to use these samples to develop and test future countermeasures (like treatments) against COVID-19 and other viruses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) have a positive test for COVID-19 or another listed respiratory virus, or you had COVID-19 more than 14 days ago, or you were possibly exposed and developed antibodies
- You must be able to give consent (or a parent/guardian can give permission for a child)
- If you’re enrolling in the COVID-19 antibody/exposure group, you should have signs your body made antibodies to COVID-19
- If you are a child, you must be at least 6 months old
- Your blood counts must meet safety thresholds: hemoglobin 7 or higher and platelets 80 or higher
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects sent-in samples to better understand how your immune system responds during a COVID-19–like illness and after you recover. It may help researchers learn why some people get sick and others stay uninfected, and how immune protection works over time.
This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.
This study collects samples from people who have or might have a cold/respiratory virus, then stores them for future research. It may help researchers better understand respiratory germs and develop better treatments.
This study looks at how the immune system in the body responds to different COVID-19 virus variants. It may help improve how COVID-19 is diagnosed by comparing people who are currently infected and those who are not.
This study collects extra blood or other samples from people who are already getting routine COVID-19 tests or monitoring. The samples are used to better understand how the virus affects the body and to improve future testing.
This study looks at immune (infection-fighting) cells in people who have previously joined certain healthy volunteer research groups. It may help researchers better understand how the immune system responds to coronavirus infections, including COVID-19.
Hear when a new Covid19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.